Updated:
Panacea Venture Advisors (HK) Limited
Panacea Venture Advisors (HK) Limited is incorporated in Hong Kong and functions as a family office vehicle for venture-stage investing.
Panacea Venture Advisors (HK) Limited
Panacea Venture Advisors (HK) Limited is incorporated in Hong Kong and functions as a family office vehicle for venture-stage investing. While specific founding details and wealth origin are not publicly available, the firm's name and registration suggest a connection to Asian family capital. The entity was established under the Hong Kong Companies Registry, indicating a formal structure typical of family offices managing concentrated wealth. The firm's investment strategy centers on venture capital, with a discernible emphasis on healthcare and technology sectors. Its portfolio includes direct investments in companies such as JW Pharmaceutical, a South Korean biopharma firm, and 3D Medicines, a precision oncology platform. Geographically, Panacea deploys capital across Asia, with known positions in both China and South Korea, often co-investing alongside other institutional investors. Team size and additional offices remain undisclosed. Panacea does not publicize a professional count or external management structure, consistent with a lean single-family office model. No philanthropic foundation or adjacent vehicles have been identified in public records. The firm maintains a low public profile, with limited operational updates beyond corporate filings. A key structural differentiator is Panacea's tight focus on life sciences venture investing from an Asian base, operating as a single-family office that makes direct co-investments rather than through fund-of-funds. This profile is distinctive among Hong Kong family offices, which more commonly diversify across real estate or public markets.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Hong Kong
Corporate office
Hong Kong, China
Sector focus
Frequently asked questions
What is Panacea Venture Advisors' investment strategy?
Panacea focuses on venture capital investments, primarily in healthcare and technology sectors. Known positions include life sciences companies in Asia, such as JW Pharmaceutical and 3D Medicines (per South Korean and Chinese corporate disclosures).
How does Panacea Venture Advisors source deals?
As a family office, Panacea likely leverages networks in Asian healthcare and technology ecosystems. Direct co-investments and participation in syndicated rounds are typical methods, though the firm's specific sourcing model is not publicly disclosed.
Does Panacea Venture Advisors manage external capital?
No evidence indicates Panacea manages third-party capital. It appears structured as a single-family office managing the wealth of a private family, with no registered investment advisor filings suggesting external clients.
What geographic regions does Panacea focus on?
Panacea's known investments are in Asia, particularly China and South Korea. The firm's Hong Kong base allows access to regional venture markets, though publicly visible deals are concentrated in these two countries.
How is Panacea Venture Advisors related to other entities?
No corporate parent or spinout relationships are documented in public filings. The entity operates independently under its Hong Kong registration, with no known connection to other Panacea-branded funds or entities.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: